The Enterprise Value as of December 2025 (TTM) for Raphael Pharmaceutical Inc. (RAPH) is 19.65M

According to Raphael Pharmaceutical Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 19.65M. This represents a change of 11.99% compared to the average of 17.54M of the last 4 quarters.

Raphael Pharmaceutical Inc. (RAPH) Historical Enterprise Value (quarterly & annually)

How has RAPH Enterprise Value performed in the past?

The mean historical Enterprise Value of Raphael Pharmaceutical Inc. over the last ten years is 21.63M. The current 19.65M Enterprise Value has changed 8.98% with respect to the historical average. Over the past ten years (40 quarters), RAPH's Enterprise Value was at its highest in in the September 2024 quarter at 30.82M. The Enterprise Value was at its lowest in in the December 2024 quarter at 5.00M.

Raphael Pharmaceutical Inc. (RAPH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Raphael Pharmaceutical Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Raphael Pharmaceutical Inc. (RAPH) Average Enterprise Value

How has RAPH Enterprise Value performed in the past?

The current Enterprise Value of Raphael Pharmaceutical Inc. (RAPH) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Raphael Pharmaceutical Inc. (RAPH) Enterprise Value vs. Peers

How is RAPH’s Enterprise Value compared to its peers?

Raphael Pharmaceutical Inc.’s Enterprise Value is greater than Isracann Biosciences Inc. (2.43M), less than Voyageur Pharmaceuticals Ltd. (27.32M), less than Avicanna Inc. (28.10M), less than Global Pharmatech, Inc. (20.82M), greater than MediPharm Labs Corp. (17.53M), greater than INDVR Brands Inc. (3.21M), greater than Molecule Holdings Inc. (5.60M), less than Choom Holdings Inc. (30.10M), less than Elbit Imaging Ltd. (30.34M), greater than Mydecine Innovations Group Inc. (18.04M),

Build a custom stock screener for Raphael Pharmaceutical Inc. (RAPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Raphael Pharmaceutical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Raphael Pharmaceutical Inc. (RAPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Raphael Pharmaceutical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.